Comparison of the Levels of Tumor Necrosis Factor-α and Interleukin-17 in Gingival Crevicular Fluid of Patients with Peri-implantitis and a Control Group with Healthy Implants
Abstract
Peri-implantitis is a multi-factorial disease involving peri-implant tissues and resulting in therapeutic failure. Inflammatory mediators and cytokines in the Gingival Crevicular Fluid (GCF) have pivotal roles in the disease pathogenesis and could be used for disease monitoring. Therefore, the present study was conducted to compare the GCF levels of TNF-α and IL-17 between patients with peri-implantitis and healthy implants.
In this case-control study, 24 patients with peri-implantitis and 18 individuals with healthy implants referring to faculty of dentistry in Tehran University of Medical Sciences were selected. GCF was collected by paper cons number 30. Samples were preserved in PBS -70ºC. TNF-α and IL-17 levels in GCF were determined by ELISA method. Data were analyzed by SPSS software version 13, using descriptive indices and independent t tests.
Mean probing depth in peri-implantitis and control groups were 6.2 ± 1.1 and 3.7 ± 1.6 mm respectively. Mean level of IL-17 in patients with peri-implantitis was significantly more than the control group (19.8 ± 16.0 versus 9.3 ± 8.4 pg per site in 40 seconds, p=0.016). Also, mean level of TNF-α in patients with peri-implantitis was more than control group (39.0 ± 3.9 versus 14.5 ± 9.0 pg per site in 40 seconds, p =0.000).
The significant higher levels of TNF-α and IL-17 in patients with peri-implantitis compared to control group indicated the pivotal role of these cytokines in peri-implantitis and could be suggested as diagnostic markers and in future possibly for immunomodulatory treatments.
1. Andreiotelli M, Koutayas SO, Madianos PN, Strub JR.Relationship between interleukin-1 genotype and peri- implantitis: a literature review. Quintessence Int 2008;39(4):289-98.
2. Troen BR. Molecular mechanisms underlying osteoclast formation and activation. Exp Gerontol 2003; 38: 605-14.
3. Boyce BF, Li P, Yao Z, Zhang Q, Badell IR, Echwarz EM, et al. TNF-alpha and pathologic bone resorption. Keio J Med 2005; 54(3):127-31.
4. Seymour GJ, Gemmell E. Cytokines in periodontal disease: Where to from here? Acta Odontol Scand 2001;59:167-73.
5. Petković-Ćurčin A, Matić S, Vojvodić D, Stamatović N, Todorović T. Cytokines in pathogenesis of peri- implantitis. Vojnosaniti Pregl 2004, 68(5): 435-40.
6. Esposito M, Hirsch J, Lekholm U, Thomsen P. Differential diagnosis and treatment strategies for biologic complications and failing oral implants: a review of the literature. Int J Oral Maxillofac Implants 1999; 14(4):473–490.
7. Mombelli A, Lang NP. The diagnosis and treatment of peri-implantitis. Periodontol 1998; 17:63–76.
8. Panagakos FS, Aboyoussef H, Dondero R, Jandinski JJ.Detection and measurement of inflammatory cytokines in implant crevicular fluid: a pilot study. Int J Oral Maxillofac Implants 1996; 11(6):794-9.
9. Bartold PM, Narayana AS. Biology of the periodontal connective tissue. 1st ed. Chicago:Quintessence publishing, 1998. Chap-10.
10. Page RC. Host response test for diagnosis periodontal diseases. J periodontol 1992; 63:356-66.
11. Goodson JM, Haffajee AD, Socransky SS. The relationship between attachment level loss and alveolar boneless. J clin periodontol 1984; 11(5):384-59.
12. Greenstein G, Caton J. periodontal diseases activity: a critical assessment. J periodontol 1990; 61(9):543-62.
13. Embery G, Waddington R. Gingival crevicular fluid:biomarkers of periodontal tissue activity. Adv Dent Res 1994; 8(2):329-31.
14. Adongianaki E, Mgoney J, Kinane DF. The ability of gingival crevicular fluid acute phase proteins to distinguish healthy, gingivitis and periodontitis sites. J clin periodontol 1992; 19(2):98-102.
15. Arnold R, Lunstad G, Bissada N, Stallard R. Alternations in crevicular fluid flow during healing following gingival surgery. J Periondontal Res 1996; 1(4):303-11.
16. Delima AJ, Oates T, Assuma R, Schwartz Z, Cochran D,Amar S, Graves DT. A soluble antagonist to IL-1 and TNF inhibits loss of tissue attachment in experimental periodontitis. J clin periodontol 2001; 28(3):233-40.
17. Graves DT, Cochran D. The contribution of IL-1 and TNF to periodontal tissue destruction. J periodontol 2003;74(3):391-401.
18. Hamdy AA, Ebrahem MA. The Effect of Interleukin-1Allele 2 Genotype (IL-1a (-889) and IL-1b (+3954)) on the Individual's Susceptibility to Peri-Implantitis: Case- Control Study. J Oral Implantol 2011; 37(3):325-34.
19. Laine ML, Leonhardt A, Roos-Jansåker AM, Peña AS, van Winkelhoff AJ, Winkel EG, et al. IL-1RN gene polymorphism is associated with peri-implantitis. Clin Oral Implants Res 2006; 17(4):380-5.
20. Huynh-Ba G, Lang NP, Tonetti MS, Zwahlen M, Salvi GE. Association of the composite IL-1 genotype with peri-implantitis: a systematic review. Clin Oral Implants Res 2008; 19(11):1154-62.
21. Wilson TG Jr, Nunn M. The relationship between the interleukin-1 periodontal genotype and implant loss. Initial data. J Periodontol 1999; 70(7):724-9.
22. Greenstein G, Hart TC. Clinical utility of a genetic susceptibility test for severe chronic periodontitis: a critical evaluation. J Am Dent Assoc 2002; 133(4):452-9.
23. Lachmann S, Kimmerle-Müller E, Axmann D, Scheideler L, Weber H, Haas R. Associations between peri-implant crevicular fluid volume, concentrations of crevicular inflammatory mediators, and composite IL-1A -889 andIL-1B +3954 genotype. A cross-sectional study on implant recalls patients with and without clinical signs of peri-implantitis. Clin Oral Implants Res 2007; 18(2):212-23.
24. Melo RF, Lopes BM, Shibli JA, Marcantonio Junior E, Marcantonio RA, Galli GM. Interleukin-1β and interleukin-6 expression and gene polymorphisms in subjects with peri-implant disease. Clin Implant Dent Relat Res 2011; 17:10.
25. Javed F, Al-Hezaimi K, Salameh Z, Almas K, Romanos GE. Proinflammatory cytokines in the crevicular fluid of patients with peri-implantitis. Cytokine 2011; 53(1):8-12.
26. Ataoglu H, Alptekin NO, Haliloglu S, Gursel M, Ataoglu T, Serpek B, et al. Interleukin-1beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri- implant crevicular fluid. Clin Oral Implants Res 2002;13(5):470-6.
27. Liskmann S, Vihalemm T, Salum O, Zilmer K, Fischer K, Zilmer M. Correlations between clinical parameters and interleukin-6 and interleukin-10 levels in saliva from totally edentulous patients with peri-implant disease. Int J Oral Maxillofac Implants 2006; 21(4):543-50.
28. Konttinen YT, Lappalainen R, Laine P, Kitti U,Santavirta S, Teronen O. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics Restorative Dent 2006; 26(2):135-41.
29. Duarte PM, de Mendonça AC, Máximo MB, Santos VR,Bastos MF, Nociti Júnior FH. Differential cytokine expressions affect the severity of peri-implant disease. Clin Oral Implants Res 2009; 20(5):514-20.
30. Curtis DA, Kao R, Plesh O, Finzen F, Franz L. Crevicular fluid analysis around two failing dental implants: a clinical report. J Prosthodont 1997; 6(3):210-4.
31. Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y, et al. Osteocalcin, deoxypyridinoline and interleukin-1beta in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res 2002; 13(6):637-43.
32. Konttinen YT, Lapplinen R, Laine P, Kitti U, Santavirta S, Teronen O. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics restorative Dent 2006; 26(2):135-41.
33. De mendonca AC, Santos VR, Cesar-Neto JB, Duarte PM. Tumor Necrosis factor-alpha level after surgical anti infective therapy for peri-implantitis: a 12 month follow up; J Periodontal 2009; 80(4):693-9.
34. Duarte PM, De Mendonca AC, Maximom MB, Santos VR, Bastos BF, Nociti FH. Effect of anti infective mechanical therapy on clinical parameters and cytokine levels in human peri implant diseases: J Periodontal 2009;80(2):234–43.
35. Vernal R, Dutzan N, Chaparro A, Puente J, Antonieta Valenzuela M, Gamonal G. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005; 32(4):383-9.
36. Beklen A, Ainola M, Hukkanen M, Gürgan C, Sorsa T, Konttinen YT. MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 2007; 86(4):347-51.
37. Severino VO, Napimoga MH, de Lima Pereira SA.Expression of IL-6, IL-10, IL-17 and IL-8 in the peri- implant crevicular fluid of patients with peri-implantitis. Arch Oral Biol 2011; 56(8):823-8.
38. Page RC, Kornman KS. The pathogenesis of human periodontitis: An introduction. Periodontol 1997;14(1):9–11.
39. Zou DR, Zhu H, Qu XH. Detection and measurement of interleukin-8 in peri-implant crevicular fluid. Hua Xi Kou Qiang Yi Xue Za Zhi 2005; 23(4):292-4.
40. Petković A. Significance of proinflammatory (IL1β, TNFα, MIP1α i IL8) and peri-implant sulcus fluid [thesis]. Belgrade: Military Medical Academy; 2005. (Serbian)
41. Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Toz H, et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: Implications of their relative ratio J Clin Periodontol 2007; 34(5):370-76.
42. Konttinen YT, Lappalainen R, Laine P, Kitti U, Santavirta S, Teronen O. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics Restorative Dent 2006; 26(2):135-41.
43. Schenkein HA, Koertge TE, Brooks CN, Sabatini R, Purkall DE, Tew JG. IL-17 in sera from patients with aggressive periodontitis. J Dent Res 2010; 89(9):943-7.
| Files | ||
| Issue | Vol 12, No 1 (2013) | |
| Section | Articles | |
| Keywords | ||
| IL-17 Implant Peri-implantitis TNF- α | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
